The US Food and Drug Administration (FDA) held a 2-day public hearing this week to solicit input about the marketing and use of medications and medical devices for off-label use. It is fairly common ...

It seemed like only a matter of time before someone would close this valve. After months of off-label prescribing of Ozempic, propelled by celebrity hype of the diabetes drug which has gained ...

In March 2023, I started working at a large retail pharmacy as a technician. Bright-eyed and bushy-tailed, I donned my crisp, blue technician’s uniform complete with my slightly lopsided name tag on ...

Developers of a cutting-edge lab-grown blood vessel designed to save life and limb in war zones and other emergency scenarios ...

As common—and costly—as off-label prescribing is in oncology, it is poorly understood. It is, by nature, hard to study. Yet it is clear that the practice is changing. Skyrocketing drug costs, ...

In a continuing shift of enforcement strategy, the U.S. Department of Justice (DOJ) has firmly taken control of off-label use allegations against pharmaceutical, biotechnology, and medical device ...

With the off-label/intended use controversy still simmering, a bill has debuted in the U.S. House of Representatives that would restrict the federal government's ability to pursue charges against ...

Off-label prescribing is when a medication is prescribed for a purpose not approved by the FDA. Insurance might cover off-label prescriptions, but it depends on the specific plan and often requires a ...

An off-label prescription drug has been shown to help some non-verbal children with autism discover the ability to speak. The drug, leucovorin, is a prescription vitamin that functions similarly to ...

Wait Times for Breast Cancer Surgery: Effect of Magnetic Resonance Imaging and Preoperative Investigations on the Diagnostic Pathway Oral oncolytics are becoming increasingly utilized for cancer ...

Dipa Kamdar does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...